Bob Azelby is the founder of Eliem Therapeutics. Eliem Therapeutics has raised $80M in total funding. Latest round: Series A. Based in Seattle, United States.
Bob Azelby is a co-founder and leader of Eliem Therapeutics, a Seattle-based biotech startup that focuses on therapies for pain and depression. He previously held executive positions at Juno Therapeutics and Alder Biopharmaceuticals. Eliem Therapeutics raised $80 million in funding under his leadership.
Full founder directory · Investor directory · Company funding database · Fundraising library